72 research outputs found

    A local spectral condition for strong compactness with some applications to bilateral weighted shifts

    Get PDF
    An algebra of bounded linear operators on a Banach space is said to be strongly compact if its unit ball is precompact in the strong operator topology, and a bounded linear operator on a Banach space is said to be strongly compact if the algebra with identity generated by the operator is strongly compact. Our interest in this notion stems from the work of Lomonosov on the existence of invariant subspaces. We provide a local spectral condition that is sufficient for a bounded linear operator on a Banach space to be strongly compact. This condition is then applied to describe a large class of strongly compact, injective bilateral weighted shifts on Hilbert spaces, extending earlier work of Fernández-Valles and the first author. Further applications are also derived, for instance, a strongly compact, invertible bilateral weighted shift is constructed in such a way that its inverse fails to be a strongly compact operator.Ministerio de Ciencia e InnovaciónJunta de Andalucí

    On statistical convergence and strong Cesaro convergence by moduli for double sequences

    Get PDF
    A remarkable result on summability states that the statistical convergence and the strong Cesàro convergence are closely connected. Given a modulus function f, we will establish that a double sequence that is f -strong Cesàro convergent is always f -statistically convergent. The converse, in general, is false even for bounded sequences. However, we will characterize analytically the modulus functions f for which the converse of this result remains true. The results of this paper adapt to several variables the results obtained in (León-Saavedra et al. in J. Inequal. Appl. 12:298, 2019)

    On ℓ∞- Grothendieck subspaces

    Get PDF
    A closed subspace S of l - is said to be a l -Grothendieck subspace if co c S (hence l - c S**) and every [sigma] (S*, S)-convergent sequence in S* is [sigma](S*, l)-convergent. Here we give examples of closed subspaces of l- containing co which are or fail to be l -Grothendiec.The authors were supported by Ministerio de Ciencia, Innovación y Universidades (Spain), grants PGC2018-101514-B-I00, PID2019-103961GB-C22, and by Vicerrectorado de Investigación de la Universidad de Cádiz. This work was also co-financed by the 2014-2020 ERDF Operational Programme, and by the Department of Economy, Knowledge, Business and University of the Regional Government of Andalusia, project reference: FEDER-UCA18-108415

    Powers of Convex-Cyclic Operators

    Get PDF
    A bounded operator T on a Banach space X is convex cyclic if there exists a vector x such that the convex hull generated by the orbit Tnxn≥0 is dense in X. In this note we study some questions concerned with convex-cyclic operators. We provide an example of a convex-cyclic operator T such that the power Tn fails to be convex cyclic. Using this result we solve three questions posed by Rezaei (2013)

    On statistical convergence and strong Cesàro convergence by moduli

    Get PDF
    In this paper we will establish a result by Connor, Khan and Orhan (Analysis 8:47–63, 1988; Publ. Math. (Debr.) 76:77–88, 2010) in the framework of the statistical convergence and the strong Cesàro convergence defined by a modulus function f . Namely, for every modulus function f , we will prove that a f -strongly Cesàro convergent sequence is always f -statistically convergent and uniformly integrable. The converse of this result is not true even for bounded sequences. We will characterize analytically the modulus functions f for which the converse is true. We will prove that these modulus functions are those for which the statistically convergent sequences are f -statistically convergent, that is, we show that Connor–Khan–Orhan’s result is sharp in this sense

    Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Get PDF
    [Background] Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma (CTCL) after at least one previous systemic treatment. However, real clinical practice is still limited.[Objectives] To evaluate the response and tolerance of BV in a cohort of patients with CTCL.[Methods] We analysed CTCL patients treated with BV from the Spanish Primary Cutaneous Lymphoma Registry (RELCP).[Results] Sixty-seven patients were included. There were 26 females and the mean age at diagnosis was 59 years. Forty-eight were mycosis fungoides (MF), 7 Sézary syndrome (SS) and 12 CD30+ lymphoproliferative disorders (CD30 LPD). Mean follow-up was 18 months. Thirty patients (45%) showed at least 10% of CD30+ cells among the total lymphocytic infiltrate. The median number of BV infusions received was 7. The overall response rate (ORR) was 67% (63% in MF, 71% in SS and 84% in CD30 LPD). Ten of 14 patients with folliculotropic MF (FMF) achieved complete or partial response (ORR 71%). The median time to response was 2.8 months. During follow-up, 36 cases (54%) experienced cutaneous relapse or progression. The median progression free survival (PFS) was 10.3 months. The most frequent adverse event was peripheral neuropathy (PN) (57%), in most patients (85%), grades 1 or 2.[Conclusions] These results confirm the efficacy and safety of BV in patients with advanced-stage MF, and CD30 LPD. In addition, patients with FMF and SS also showed a favourable response. Our data suggest that BV retreatment is effective in a proportion of cases.The Spanish Primary Cutaneous Lymphoma Registry (RELCP) is promoted by the Fundación Piel Sana Academia Española de Dermatología y Venereología, which received an unrestricted grant support from Kyowa Kirin.Peer reviewe

    Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design

    Get PDF
    Introduction: We present the protocol of a large population-based case-control study of 5 common tumors in Spain (MCC-Spain) that evaluates environmental exposures and genetic factors. Methods: Between 2008-2013, 10,183 persons aged 20-85 years were enrolled in 23 hospitals and primary care centres in 12 Spanish provinces including 1,115 cases of a new diagnosis of prostate cancer, 1,750 of breast cancer, 2,171 of colorectal cancer, 492 of gastro-oesophageal cancer, 554 cases of chronic lymphocytic leukaemia (CLL) and 4,101 population-based controls matched by frequency to cases by age, sex and region of residence. Participation rates ranged from 57% (stomach cancer) to 87% (CLL cases) and from 30% to 77% in controls. Participants completed a face-to-face computerized interview on sociodemographic factors, environmental exposures, occupation, medication, lifestyle, and personal and family medical history. In addition, participants completed a self-administered food-frequency questionnaire and telephone interviews. Blood samples were collected from 76% of participants while saliva samples were collected in CLL cases and participants refusing blood extractions. Clinical information was recorded for cases and paraffin blocks and/or fresh tumor samples are available in most collaborating hospitals. Genotyping was done through an exome array enriched with genetic markers in specific pathways. Multiple analyses are planned to assess the association of environmental, personal and genetic risk factors for each tumor and to identify pleiotropic effects. Discussion: This study, conducted within the Spanish Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), is a unique initiative to evaluate etiological factors for common cancers and will promote cancer research and prevention in Spain.The study was partially funded by the “Accion Transversal del Cancer”, approved on the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773, PS09/01286, PS09/01903, PS09/02078, PS09/01662, PI11/01403, PI11/01889, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150), by the Fundación Marqués de Valdecilla (API 10/09), by the ICGC International Cancer Genome Consortium CLL, by the Junta de Castilla y León (LE22A10-2), by the Consejería de Salud of the Junta de Andalucía (PI-0571), by the Conselleria de Sanitat of the Generalitat Valenciana (AP 061/10), by the Recercaixa (2010ACUP 00310), by the Regional Government of the Basque Country by European Commission grants FOOD-CT- 2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation, by the The Catalan Government DURSI grant 2009SGR1489

    Diseño para el consumo cultural, la innovación y la inclusión social

    Get PDF
    Esta obra presenta diversos trabajos de investigación que tienen en común propuestas de diseño desde la cultura, la inclusión y la innovación social, desarrolladas por investigadores nacionales e internacionales adscritos a diversas universidades, así como a programas de posgrado
    corecore